# A Multicenter, Open-label, RebiSmart™ Autoinjector Ease of Use Study

> **NCT01036165** · PHASE3 · COMPLETED · sponsor: **EMD Serono** · enrollment: 103 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DEVICE:** RebiSmart™

## Key facts

- **NCT ID:** NCT01036165
- **Lead sponsor:** EMD Serono
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2013-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01036165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01036165, "A Multicenter, Open-label, RebiSmart™ Autoinjector Ease of Use Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01036165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*